GGrantIndex
Sort

53,477 grants matching addiction

Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD)

$2,587,255
David A Smelson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · MH

Center for Systems Neurogenetics of Addiction

$2,587,082
Elissa J Chesler · Jackson Laboratory · P50 · FY2016 · DA

Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?

$2,584,873
Kyle Matthew Kampman · University Of Pennsylvania · UH3 · FY2025 · DA

Center for Methodologies for Adapting and Personalizing Prevention, Treatment and Recovery Services for SUD and HIV (MAPS Center)

$2,584,185
Inbal Billie Nahum-Shani · University Of Michigan At Ann Arbor · P50 · FY2024 · DA

The Molecular Drivers and Therapeutic Susceptibilities in Lineage State Transitions of Metastatic Prostate Cancer

$2,579,971
Joshua Michael Lang · University Of Wisconsin-Madison · P01 · FY2025 · CA

Development of an Opioid Sparing Therapeutic to Minimize Opioid Use Disorderand Tolerance in the Treatment of Pain

$2,579,875
Malcolm A Meyn · Amalgent Therapeutics, Inc. · R44 · FY2023 · DA

Harvard PRECISION Human Pain Center

$2,578,553
William Russell Renthal · Brigham And Women'S Hospital · U19 · FY2023 · NS

Rural Drug Addiction Research Center

$2,575,854
Kirk Dombrowski · University Of Nebraska Lincoln · P20 · FY2019 · GM

The Maternal and Reproductive Community Health Excellence (MaRCH) Center of Biomedical Research Excellence (COBRE)

$2,575,150
Pearl McElfish · Univ Of Arkansas For Med Scis · P20 · FY2025 · GM

Combination Therapies to Defeat Melanoma Resistance

$2,574,738
Antoni Ribas · University Of California Los Angeles · P01 · FY2020 · CA

Harvard PRECISION Human Pain Center

$2,574,551
William Russell Renthal · Brigham And Women'S Hospital · U19 · FY2024 · NS

Mouse models of stress disorders and addiction

$2,573,710
Andrew Holmes · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2018 · AA

1-Year Sustained Release Naltrexone Implant for the prevention of relapse to opioid dependence

$2,572,678
Frank J Martin · Delpor, Inc. · UG3 · FY2019 · DA

Center to Advance Research Excellence (OPTIC)

$2,571,099
Bradley D Stein · Rand Corporation · P50 · FY2024 · DA

Harvard PRECISION Human Pain Center

$2,570,113
William Russell Renthal · Brigham And Women'S Hospital · U19 · FY2025 · NS

HEALTH Center for Addictions Research and Cancer Prevention

$2,567,469
Ezemenari M Obasi · University Of Houston · U54 · FY2022 · MD

Community Clinical Oncology Program

$2,566,072
Mayo Clinic · U10 · FY2004 · CA

Mouse models of stress disorders and addiction

$2,565,800
Andrew Holmes · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA

Development of MRI Techniques for Applications in Substance Use Disorders

$2,565,601
Yihong Yang · National Institute On Drug Abuse · ZIA · FY2024 · DA

Neuroimaging and neuromodulation of preclinical models of substance use disorders

$2,565,601
Yihong Yang · National Institute On Drug Abuse · ZIA · FY2024 · DA

Defining Melanoma Therapeutic Avenues by Integrative Functional Genomics

$2,565,000
Levi Alexander Garraway · Dana-Farber Cancer Inst · DP2 · FY2007 · OD

Cerebral Structural and Metabolic Correlates of Aggressive or Addictive Behavior

$2,562,361
Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA

Spinal Manipulation and Patient Self-Management to Prevent Back Pain Chronicity

$2,560,909
Gert Bronfort · University Of Minnesota · UH3 · FY2020 · AT

Use of a GLP-1 Agonist to Treat Opioid Use Disorder in Rats and Man

$2,557,628
Patricia Sue Grigson · Pennsylvania State Univ Hershey Med Ctr · UG3 · FY2020 · DA

Center to Advance Research Excellence (OPTIC)

$2,556,863
Bradley D Stein · Rand Corporation · P50 · FY2023 · DA